According to the new market research Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350
The key factors driving the growth of this market include increasing prevalence of cancer, initiatives undertaken by government and global health organizations, increasing preference for non-invasive procedures, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D.
North America is expected to dominate the market in 2017
North America is expected to account for the largest share of the liquid biopsy market in 2017, followed by Europe. A number of factors such as the easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, rising prevalence of cancer in the US and Canada, technological advancements in liquid biopsy products, and growing public and private funding to support research activities in the field of liquid biopsy are aiding market growth in the region.
By circulating biomarkers, circulating tumor cells is expected to account for the largest market share in 2017
Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. In 2017, the circulating tumor cells segment is expected to account for the largest share of the liquid biopsy devices market. The ability for early assessment of patient prognosis and also providing valuable information to make a clinical decision is driving the growth of the CTC segment in the liquid biopsy market.
By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017
Based on clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The therapy selection segment is expected to account for the largest share of the liquid biopsy devices market in 2017. This is due to the ability of therapy selection to detect advanced-stage cancers (stage III and IV), followed by increasing studies on liquid biopsy and advancements made in this field to also aid in detection of early-stage cancers.
By product, the assay kits segment is expected to account for the largest share of the market in 2017
On the basis of product, the liquid biopsy market is broadly segmented into assays kits, instruments, and services. In 2017, the assay kits segment is expected to account for the largest share of this market. The increase in basic research and commercial applications of liquid biopsy, increase in demand for liquid biopsy tests, and the need for reliable and specific assays are expected to drive the market growth.
By application, the cancer segment is expected to account for the largest market share in 2017
Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which includes reproductive health and organ transplant diagnostics). In 2017, cancer applications segment is expected to account for the largest share of the liquid biopsy devices market. Increasing prevalence of cancer and the growing number of research studies on liquid biopsy for cancer applications is driving the growth of this market.
By end user, the reference laboratories segment is expected to account for the largest market share in 2017
Based on end user, the liquid biopsy devices market is segmented into reference laboratories, hospitals and physician laboratories, academic and research centers, and other end users (public health laboratories, pathology laboratories, and small molecular laboratories). Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market. The large share of this segment is attributed to the increasing volume of liquid biopsy test samples outsourced to reference laboratories.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=13966350
The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
Liquid Biopsy Market Size, Share, Trend - Analysis Report 2022
0
MORE FROM AUTHOR
Zupyak is the world’s largest content marketing community, with over
400 000 members and 3 million articles. Explore and get your content
discovered.
Read more
Press enter to search
The global Liquid Biopsy Market is estimated to be valued at Us$ 13,220. 5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Segment Analysis The global liquid biopsy market is segmented based on circulating biomarkers, cancers types, applications, end-users and regions. North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. The global liquid biopsy market size was valued at US$ 13,220.
0
Other types of liquid biopsy can involve analyzing other bodily fluids such as urine, saliva, or cerebrospinal fluid. Monitoring cancer progression: Liquid biopsy can be used to monitor the progression of cancer and track the effectiveness of treatment. According to a report by BIS Research, the global liquid biopsy market size was valued at $2,508. As the technology continues to improve and become more widely adopted, we can expect to see continued growth in the liquid biopsy market. Get Free Sample Report on Liquid Biopsy Market - Click HereConclusionLiquid biopsy is a promising new technology that has the potential to revolutionize cancer diagnosis and treatment.
0
In the world of medical diagnostics, liquid biopsy has emerged as a groundbreaking technology, especially in the field of cancer detection. The global liquid biopsy market's staggering growth shows a revenue close to US$4 Bn in 2021, with an impressive CAGR of 17. According to Fairfield Market Research, this market is expected to reach a valuation of US$15. Growing Need for Liquid Biopsy in Cancer DetectionCancer, being the second leading cause of death globally, is seeing a surge in incidence. Conclusion: The Future of Liquid Biopsy MarketWith an impressive projected growth rate and a multitude of applications, the liquid biopsy market is positioned to revolutionize cancer diagnostics.
0
Global circulating tumor cells (CTC) liquid biopsy market is expected to gain market growth in the forecast period of 2022 to 2029. The circulating tumor cells are a rare sub-set of cells which function as a seed of metastases. The testing of circulating tumor cells allows the detection and quantification of tumor cells in the blood of cancer patients. The various types of biological phenotypes of circulating tumor cells (CTCs) exits includes stem cell-like or mixed, mesenchymal or epithelial. About Data Bridge Market Research, Private LtdData Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada.
0
The Business Research Company’s Liquid Biopsy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Liquid Biopsy Global Market Report 2023 evaluates liquid biopsy market size, growth rate, drivers, trends, and major companies. id=2815&type=smp The global liquid biopsy market size will grow from $5. The market size of global liquid biopsy is expected to grow to $20. Africa Liquid Biopsy Market27.
0
The global liquid biopsy market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of the liquid biopsy market is attributed to increasing cancer incidences and low treatment rates. The Cost-effectiveness and high efficacy of liquid biopsy over several other diagnostic tests are chief factors responsible for market growth. com/reports/liquid-biopsy-marketKey Segments Profiled in the Liquid Biopsy Industry SurveyLiquid Biopsy Market by Marker Type:CTCs (Circulating Tumour Cells)ctNA (Circulating tumor Nucleic Acids)ExosomesLiquid Biopsy Market by Sample Type:Blood Liquid BiopsyUrine Liquid BiopsyOthers (Plasma, Saliva, CSF) Liquid BiopsyLiquid Biopsy Market by Application Type:Liquid Biopsy for Lung CancerLiquid Biopsy for Gastrointestinal CancerLiquid Biopsy for Prostate CancerLiquid Biopsy for Breast CancerLiquid Biopsy for Colorectal CancerLiquid Biopsy for Leukemia
0
However, the lower sensitivity of some liquid biopsies may restrain the United States liquid biopsy market growth in the forecast period. Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United States Liquid Biopsy Market"https://www. On the basis of the product & services, the United States liquid biopsy market is divided into assay kits, instruments, services. On the basis of end user, the United States liquid biopsy market is divided into hospitals & clinics, reference laboratories, and others. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States liquid biopsy market.
0
The Breast Cancer Liquid Biopsy Market Scope and SizeThis Breast Cancer Liquid Biopsy Market research document has been prepared by considering several fragments of the present and upcoming market scenario. Moreover, Breast Cancer Liquid Biopsy Market report explains better market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. To gain actionable market insights to build sustainable and money-spinning business strategies with an ease, Breast Cancer Liquid Biopsy market research report is a great optionThis Breast Cancer Liquid Biopsy market research report encompasses a far-reaching research on the current conditions of the Medical Devices industry, potential of the market in the present and the future prospects. com/reports/global-breast-cancer-liquid-biopsy-marketKey Players Breast Cancer Liquid Biopsy MarketJohnson & Johnson Private Limited. , Cynvenio AI, Inc other domestic and global playersMAJOR TOC OF THE REPORTChapter One: Breast Cancer Liquid Biopsy Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Breast Cancer Liquid Biopsy Market Competition, by PlayersChapter Four: Breast Cancer Liquid Biopsy Market Size by RegionsChapter Five: Breast Cancer Liquid Biopsy Market Revenue by CountriesChapter Six: Breast Cancer Liquid Biopsy Market Revenue by TypeChapter Seven: Breast Cancer Liquid Biopsy Market Revenue by ApplicationChapter Eight: Breast Cancer Liquid Biopsy Market Revenue by IndustriesChapter Nine: Breast Cancer Liquid Biopsy Market Revenue by Deployment ModelChapter Ten: Breast Cancer Liquid Biopsy Market Revenue by End UserGet TOC Details: https://www.
0
The global Liquid Biopsy Market is estimated to be valued at US$ 5. Advancements in liquid biopsy technologies allowing detection of even the smallest amount of circulating tumor DNA or cells in blood is improving early cancer detection capabilities significantly. Segment AnalysisThe global liquid biopsy market is dominated by the circulating tumor cell (CTC) detection segment. Guardant Health leads the market with its proprietary Guardant360 liquid biopsy assay approved for clinical use in cancer monitoring and recurrence detection. Roche and Qiagen also have strong product portfolios in liquid biopsy kits and reagents for ctDNA detection.
0
Unlike traditional biopsies, liquid biopsy uses easily accessible samples like blood and urine, minimizing patient discomfort. By Usage: Based on the Usage, Middle East Liquid Biopsy Market is segmented as; Research Use Only, Clinical. By Sample: Based on the Sample, Middle East Liquid Biopsy Market is segmented as; Blood, Urine, Saliva. By Product: Based on the Product, Middle East Liquid Biopsy Market is segmented as; Tests/Services, Kits and Consumables, Instruments. For More Information, refer to below link:-MENA Liquid Biopsy Market RevenueRelated Reports:Stem Cell Banking Market Size- By Service Type, By Utilization, By Cell Type, By Bank Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2032Bioenergy Market Size- By Product Type, By Feedstock, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2032Follow Us – LinkedIn | Instagram | Facebook | TwitterContact Us:Sara Lopes, Business Consultant – U.
0
The global Liquid Biopsy Market size is predicted to account USD 26. A recent study by Precedence Research on the liquid biopsy market offers a forecast for 2022 and 2030. The study also provides the dynamics that are responsible for influencing the future status of the liquid biopsy market over the forecast period. A list of prominent companies operating in the liquid biopsy market along with their product portfolio enhances the reliability of this comprehensive research study. Contact Us: Precedence Research Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, CanadaCall: +1 9197 992 333Email: sales@precedenceresearch.
0
91 billion by 2030 and is anticipated to register a CAGR of 19. com/market_insight/Global-Liquid-Biopsy-Market-By-97Key Market Insights from the report:Global Liquid Biopsy Market accounted for US$ 1. 91 billion by 2030 and is anticipated to register a CAGR of 19. Based on Product Type, Global Liquid Biopsy Market is segmented into Reagents & Kits and Equipment. Based on Sample, Global Liquid Biopsy Market is segmented into Cell Free DNA, Circulating Tumor Cells, and Exosomes. Competitive Landscape & their strategies of Global Liquid Biopsy Market:The Key players operating in the liquid biopsy market include Illumina, Inc.
0
It comprises the leading-age and up-to-date information on the global Breast Cancer Liquid Biopsy Market outlook. How will the Breast Cancer Liquid Biopsy Market change in the upcoming years? Which product and application will take a share of the Breast Cancer Liquid Biopsy Market? What are the drivers and restraints of the Breast Cancer Liquid Biopsy Market? What will be the CAGR and size of the Breast Cancer Liquid Biopsy Market throughout the forecast period?
0
This technology has the potential to revolutionize the field of early cancer detection and provide patients with better outcomes. A liquid biopsy test can help determine if the patient is a good candidate for targeted therapy. From the name alone, it is evident that liquid biopsy is a quick, non-invasive method that uses a sample to perform a blood test. The Liquid Biopsy Market growth rate is being pushed by the surge in demand for better diagnosis equipment and the expansion of research labs in developing nations. The Liquid Biopsy Market growth rate is also being boosted by pharmaceutical and biopharmaceutical countries' research and development capabilities for the incorporation of cutting-edge technology in healthcare facilities.
0
The global Liquid Biopsy Market is estimated to be valued at Us$ 13,220. 5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Segment Analysis The global liquid biopsy market is segmented based on circulating biomarkers, cancers types, applications, end-users and regions. North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. The global liquid biopsy market size was valued at US$ 13,220.
The global Liquid Biopsy Market is estimated to be valued at US$ 5. Advancements in liquid biopsy technologies allowing detection of even the smallest amount of circulating tumor DNA or cells in blood is improving early cancer detection capabilities significantly. Segment AnalysisThe global liquid biopsy market is dominated by the circulating tumor cell (CTC) detection segment. Guardant Health leads the market with its proprietary Guardant360 liquid biopsy assay approved for clinical use in cancer monitoring and recurrence detection. Roche and Qiagen also have strong product portfolios in liquid biopsy kits and reagents for ctDNA detection.
Other types of liquid biopsy can involve analyzing other bodily fluids such as urine, saliva, or cerebrospinal fluid. Monitoring cancer progression: Liquid biopsy can be used to monitor the progression of cancer and track the effectiveness of treatment. According to a report by BIS Research, the global liquid biopsy market size was valued at $2,508. As the technology continues to improve and become more widely adopted, we can expect to see continued growth in the liquid biopsy market. Get Free Sample Report on Liquid Biopsy Market - Click HereConclusionLiquid biopsy is a promising new technology that has the potential to revolutionize cancer diagnosis and treatment.
Unlike traditional biopsies, liquid biopsy uses easily accessible samples like blood and urine, minimizing patient discomfort. By Usage: Based on the Usage, Middle East Liquid Biopsy Market is segmented as; Research Use Only, Clinical. By Sample: Based on the Sample, Middle East Liquid Biopsy Market is segmented as; Blood, Urine, Saliva. By Product: Based on the Product, Middle East Liquid Biopsy Market is segmented as; Tests/Services, Kits and Consumables, Instruments. For More Information, refer to below link:-MENA Liquid Biopsy Market RevenueRelated Reports:Stem Cell Banking Market Size- By Service Type, By Utilization, By Cell Type, By Bank Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2032Bioenergy Market Size- By Product Type, By Feedstock, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2032Follow Us – LinkedIn | Instagram | Facebook | TwitterContact Us:Sara Lopes, Business Consultant – U.
In the world of medical diagnostics, liquid biopsy has emerged as a groundbreaking technology, especially in the field of cancer detection. The global liquid biopsy market's staggering growth shows a revenue close to US$4 Bn in 2021, with an impressive CAGR of 17. According to Fairfield Market Research, this market is expected to reach a valuation of US$15. Growing Need for Liquid Biopsy in Cancer DetectionCancer, being the second leading cause of death globally, is seeing a surge in incidence. Conclusion: The Future of Liquid Biopsy MarketWith an impressive projected growth rate and a multitude of applications, the liquid biopsy market is positioned to revolutionize cancer diagnostics.
The global Liquid Biopsy Market size is predicted to account USD 26. A recent study by Precedence Research on the liquid biopsy market offers a forecast for 2022 and 2030. The study also provides the dynamics that are responsible for influencing the future status of the liquid biopsy market over the forecast period. A list of prominent companies operating in the liquid biopsy market along with their product portfolio enhances the reliability of this comprehensive research study. Contact Us: Precedence Research Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, CanadaCall: +1 9197 992 333Email: sales@precedenceresearch.
Global circulating tumor cells (CTC) liquid biopsy market is expected to gain market growth in the forecast period of 2022 to 2029. The circulating tumor cells are a rare sub-set of cells which function as a seed of metastases. The testing of circulating tumor cells allows the detection and quantification of tumor cells in the blood of cancer patients. The various types of biological phenotypes of circulating tumor cells (CTCs) exits includes stem cell-like or mixed, mesenchymal or epithelial. About Data Bridge Market Research, Private LtdData Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada.
The Business Research Company’s Liquid Biopsy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Liquid Biopsy Global Market Report 2023 evaluates liquid biopsy market size, growth rate, drivers, trends, and major companies. id=2815&type=smp The global liquid biopsy market size will grow from $5. The market size of global liquid biopsy is expected to grow to $20. Africa Liquid Biopsy Market27.
91 billion by 2030 and is anticipated to register a CAGR of 19. com/market_insight/Global-Liquid-Biopsy-Market-By-97Key Market Insights from the report:Global Liquid Biopsy Market accounted for US$ 1. 91 billion by 2030 and is anticipated to register a CAGR of 19. Based on Product Type, Global Liquid Biopsy Market is segmented into Reagents & Kits and Equipment. Based on Sample, Global Liquid Biopsy Market is segmented into Cell Free DNA, Circulating Tumor Cells, and Exosomes. Competitive Landscape & their strategies of Global Liquid Biopsy Market:The Key players operating in the liquid biopsy market include Illumina, Inc.
The global liquid biopsy market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of the liquid biopsy market is attributed to increasing cancer incidences and low treatment rates. The Cost-effectiveness and high efficacy of liquid biopsy over several other diagnostic tests are chief factors responsible for market growth. com/reports/liquid-biopsy-marketKey Segments Profiled in the Liquid Biopsy Industry SurveyLiquid Biopsy Market by Marker Type:CTCs (Circulating Tumour Cells)ctNA (Circulating tumor Nucleic Acids)ExosomesLiquid Biopsy Market by Sample Type:Blood Liquid BiopsyUrine Liquid BiopsyOthers (Plasma, Saliva, CSF) Liquid BiopsyLiquid Biopsy Market by Application Type:Liquid Biopsy for Lung CancerLiquid Biopsy for Gastrointestinal CancerLiquid Biopsy for Prostate CancerLiquid Biopsy for Breast CancerLiquid Biopsy for Colorectal CancerLiquid Biopsy for Leukemia
It comprises the leading-age and up-to-date information on the global Breast Cancer Liquid Biopsy Market outlook. How will the Breast Cancer Liquid Biopsy Market change in the upcoming years? Which product and application will take a share of the Breast Cancer Liquid Biopsy Market? What are the drivers and restraints of the Breast Cancer Liquid Biopsy Market? What will be the CAGR and size of the Breast Cancer Liquid Biopsy Market throughout the forecast period?
However, the lower sensitivity of some liquid biopsies may restrain the United States liquid biopsy market growth in the forecast period. Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United States Liquid Biopsy Market"https://www. On the basis of the product & services, the United States liquid biopsy market is divided into assay kits, instruments, services. On the basis of end user, the United States liquid biopsy market is divided into hospitals & clinics, reference laboratories, and others. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States liquid biopsy market.
This technology has the potential to revolutionize the field of early cancer detection and provide patients with better outcomes. A liquid biopsy test can help determine if the patient is a good candidate for targeted therapy. From the name alone, it is evident that liquid biopsy is a quick, non-invasive method that uses a sample to perform a blood test. The Liquid Biopsy Market growth rate is being pushed by the surge in demand for better diagnosis equipment and the expansion of research labs in developing nations. The Liquid Biopsy Market growth rate is also being boosted by pharmaceutical and biopharmaceutical countries' research and development capabilities for the incorporation of cutting-edge technology in healthcare facilities.
The Breast Cancer Liquid Biopsy Market Scope and SizeThis Breast Cancer Liquid Biopsy Market research document has been prepared by considering several fragments of the present and upcoming market scenario. Moreover, Breast Cancer Liquid Biopsy Market report explains better market perspective in terms of product trends, marketing strategy, future products, new geographical markets, future events, sales strategies, customer actions or behaviours. To gain actionable market insights to build sustainable and money-spinning business strategies with an ease, Breast Cancer Liquid Biopsy market research report is a great optionThis Breast Cancer Liquid Biopsy market research report encompasses a far-reaching research on the current conditions of the Medical Devices industry, potential of the market in the present and the future prospects. com/reports/global-breast-cancer-liquid-biopsy-marketKey Players Breast Cancer Liquid Biopsy MarketJohnson & Johnson Private Limited. , Cynvenio AI, Inc other domestic and global playersMAJOR TOC OF THE REPORTChapter One: Breast Cancer Liquid Biopsy Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Breast Cancer Liquid Biopsy Market Competition, by PlayersChapter Four: Breast Cancer Liquid Biopsy Market Size by RegionsChapter Five: Breast Cancer Liquid Biopsy Market Revenue by CountriesChapter Six: Breast Cancer Liquid Biopsy Market Revenue by TypeChapter Seven: Breast Cancer Liquid Biopsy Market Revenue by ApplicationChapter Eight: Breast Cancer Liquid Biopsy Market Revenue by IndustriesChapter Nine: Breast Cancer Liquid Biopsy Market Revenue by Deployment ModelChapter Ten: Breast Cancer Liquid Biopsy Market Revenue by End UserGet TOC Details: https://www.